183 related articles for article (PubMed ID: 8641010)
21. Growth hormone alone or combined with metoprolol preserves cardiac function after myocardial infarction in rats.
Bollano E; Bergh CH; Kjellström C; Omerovic E; Kujacic V; Caidahl K; Bengtsson BA; Waagstein F; Isgaard J
Eur J Heart Fail; 2001 Dec; 3(6):651-60. PubMed ID: 11738216
[TBL] [Abstract][Full Text] [Related]
22. Effects of growth hormone supplementation on left ventricular morphology and myocyte function with the development of congestive heart failure.
Houck WV; Pan LC; Kribbs SB; Clair MJ; McDaniel GM; Krombach RS; Merritt WM; Pirie C; Iannini JP; Mukherjee R; Spinale FG
Circulation; 1999 Nov; 100(19):2003-9. PubMed ID: 10556227
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of central and peripheral administration of growth hormone (GH) and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats.
Sato M; Frohman LA
Endocrinology; 1993 Aug; 133(2):793-9. PubMed ID: 8102097
[TBL] [Abstract][Full Text] [Related]
24. Effect of insulin-like growth factor I and/or growth hormone on diaphragm of malnourished adolescent rats.
Lewis MI; LoRusso TJ; Fournier M
J Appl Physiol (1985); 1997 Apr; 82(4):1064-70. PubMed ID: 9104840
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor-I liposomal gene transfer and systemic growth hormone stimulate wound healing.
Pierre EJ; Perez-Polo JR; Mitchell AT; Matin S; Foyt HL; Herndon DN
J Burn Care Rehabil; 1997; 18(4):287-91. PubMed ID: 9261692
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly.
Colao A; Marzullo P; Ferone D; Spinelli L; Cuocolo A; Bonaduce D; Salvatore M; Boerlin V; Lancranjan I; Lombardi G
J Clin Endocrinol Metab; 2000 Sep; 85(9):3132-40. PubMed ID: 10999798
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone attenuates skeletal muscle changes in experimental chronic heart failure.
Santos DP; Okoshi K; Moreira VO; Seiva FR; Almeida FL; Padovani CR; Carvalho RF; Okoshi MP; Cicogna AC; Castro AV; Pai-Silva MD
Growth Horm IGF Res; 2010 Apr; 20(2):149-55. PubMed ID: 20060348
[TBL] [Abstract][Full Text] [Related]
28. Growth hormone treatment in dilated cardiomyopathy.
Perrot A; Ranke MB; Dietz R; Osterziel KJ
J Card Surg; 2001; 16(2):127-31. PubMed ID: 11766830
[TBL] [Abstract][Full Text] [Related]
29. Organ-specific effects and interactions of acute insulin-like growth factor I (IGF-I) and growth hormone (GH).
Pascual M; Larralde J; Martínez JA
Growth Dev Aging; 1995; 59(4):181-91. PubMed ID: 8770610
[TBL] [Abstract][Full Text] [Related]
30. Echocardiographic assessment of cardiac morphology and function in mutant dwarf rats.
Longobardi S; Cittadini A; Strömer H; Katz SE; Grossman JD; Clark RG; Morgan JP; Douglas PS
Growth Horm IGF Res; 2000 Oct; 10(5):242-7. PubMed ID: 11042020
[TBL] [Abstract][Full Text] [Related]
31. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats.
Gargosky SE; Tapanainen P; Rosenfeld RG
Endocrinology; 1994 May; 134(5):2267-76. PubMed ID: 7512499
[TBL] [Abstract][Full Text] [Related]
32. Short-term administration of insulin-like growth factor I (IGF-1) does not induce myocardial IGF-1 resistance.
Ren J
Growth Horm IGF Res; 2002 Jun; 12(3):162-8. PubMed ID: 12162997
[TBL] [Abstract][Full Text] [Related]
33. Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition.
Ryoke T; Gu Y; Mao L; Hongo M; Clark RG; Peterson KL; Ross J
Circulation; 1999 Oct; 100(16):1734-43. PubMed ID: 10525494
[TBL] [Abstract][Full Text] [Related]
34. Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients.
Sesti G; Sciacqua A; Scozzafava A; Vatrano M; Angotti E; Ruberto C; Santillo E; Parlato G; Perticone F
J Hypertens; 2007 Feb; 25(2):471-7. PubMed ID: 17211256
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone increases the proliferation of existing cardiac myocytes and the total number of cardiac myocytes in the rat heart.
Brüel A; Christoffersen TE; Nyengaard JR
Cardiovasc Res; 2007 Dec; 76(3):400-8. PubMed ID: 17673190
[TBL] [Abstract][Full Text] [Related]
36. GH replacement fails to improve ventricular function in hypophysectomized rats with myocardial infarction.
Shen YT; Wiedmann RT; Lynch JJ; Grossman W; Johnson RG
Am J Physiol; 1996 Nov; 271(5 Pt 2):H1721-7. PubMed ID: 8945883
[TBL] [Abstract][Full Text] [Related]
37. Growth hormone prolongs survival in experimental postinfarction heart failure.
Cittadini A; Isgaard J; Monti MG; Casaburi C; Di Gianni A; Serpico R; Iaccarino G; Saccà L
J Am Coll Cardiol; 2003 Jun; 41(12):2154-63. PubMed ID: 12821240
[TBL] [Abstract][Full Text] [Related]
38. Growth hormone in vivo potentiates the stimulatory effect of insulin-like growth factor-1 in vitro on colony formation of epiphyseal chondrocytes isolated from hypophysectomized rats.
Lindahl A; Isgaard J; Isaksson OG
Endocrinology; 1987 Sep; 121(3):1070-5. PubMed ID: 3622376
[TBL] [Abstract][Full Text] [Related]
39. Lack of beneficial effects of growth hormone treatment in conscious dogs during development of heart failure.
Shen YT; Woltmann RF; Appleby S; Prahalada S; Krause SM; Kivilghn SD; Johnson RG; Siegl PK; Lynch JJ
Am J Physiol; 1998 Feb; 274(2):H456-66. PubMed ID: 9486248
[TBL] [Abstract][Full Text] [Related]
40. Effects of continuous infusion of insulin-like growth factor I and II, alone and in combination with thyroxine or growth hormone, on the neonatal hypophysectomized rat.
Glasscock GF; Hein AN; Miller JA; Hintz RL; Rosenfeld RG
Endocrinology; 1992 Jan; 130(1):203-10. PubMed ID: 1370151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
